A group led by Prof. Horacio Cabral, in collaboration with a group led by Prof. Kazuhiro Kakimi, discovered a new way to improve cancer immunotherapy. Their findings are published in a paper, titled "An IL-12-Based Nanocytokine Safely Potentiates Anticancer I…